Clinical trials
Observational Mobility Limitation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Unknown status | 9 |
| Recruiting | 6 |
| Not yet recruiting | 5 |
| Enrolling by invitation | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eastern Mediterranean University | 2 |
| Gazi University | 2 |
| Hacettepe University | 2 |
| Henri Mondor University Hospital | 2 |
| University Hospital, Limoges | 2 |
| University Hospital, Strasbourg, France | 2 |
| Acıbadem Atunizade Hospital | 1 |
| Ain Shams University | 1 |
| Angela Contri | 1 |
| Assiut University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mobility Limitation | 57 |
| Parkinson Disease | 7 |
| Cognitive Dysfunction | 4 |
| Gait Disorders, Neurologic | 4 |
| Stroke | 4 |
| Cerebral Palsy | 3 |
| Movement Disorders | 3 |
| Muscle Spasticity | 3 |
| Breast Neoplasms | 2 |
| COVID-19 | 2 |
Trials
Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.